Published on | 1 month ago
Programmes Digital, Industry & Space SemiconductorsThe Chips Joint Undertaking has published an update of its 2023-2027 Multiannual Work Programme, with significant updates to its strategic initiatives for 2025.
The Chips JU manages calls for funding both under Horizon Europe and Digital Europe.
An overview of the updates can be found on the Chips JU website, as is the work programme.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Culture and society Agro-Food, Environment Missions
The TIDAL ArtS project is funded under the Mission for clean oceans and inland waters and combines the power of art and science to inspire action for our ocean and waters. In april they will publish a Lighthouse call for proposals of up to 15.000 euro per artistic work. The aim of the project is notably to create public art and raise awareness on... read more
Digital, Industry & Space Cybersecurity Defence EDF
We hereby want you to give an overview of the known activities related to the EDF 2025 calls: Publication of the European Defence Fund (EDF) Work Programme 2025 infosessions: Belgian and Flanders EDF infoday on February 21st in Brussels The EDF Info Days 2025 will take place on 2-3 April in hybrid format in&n... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.